Privacy Act Review SORN

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

Attachment 16
PATH Study
NIH Privacy Act Systems of Record Notice
June 26, 2014

,.''-K

DD,PARTIIENTOT HEALTH & IIUilAN SERVICES

Public Health Service

National Institutesof Health
Bethesda,M aryland 20892

DATE:

June18.2014

TO:

KevinP. Conway,Ph.D.
DeputyDirector
Division of Epidemiology,Services,andPreventionResearch,
NationalInstituteon Drug Abuse,NIDA

FROM:

NIH Privacy Act Officer

SUBJECT: Applicability of the Privacy Act: "Population Assessmentof Tobaccoand Health
(PATH) Study (NIDA) - SecondWave of Data Collection"
I have reviewed the NIDA submissionto the OMB referencedabove. NIDA is partnering with
the Food and Drug Administration (FDA) to conduct the PATH study through Westat, the prime
contractor. Using Audio Computer-AssistedInterviews (ACASD and the collection of
biospecimens,the PATH study will collect baselineand follow-up information on tobacco-use
patterns,trends in risk perceptions,and attitudesregardingharmful constituentsfrom a cohort of
approximately 4l,7 54 civilian, non-institutionalized youth aged12 to 17, and adults aged I 8 and
older.
NIDA will use the data collected to fulfill its mission to understandsubstanceabuseand
addiction, and to generateresearchhypothesesregarding relationshipsbetweentobacco exposure
and use,health conditions, and the onset and progressionofdisease processes.
The PATH study will conduct two (2) different interviews as a meansto collection information;
the parent interview and the adult and youth extendedinterview. The parent interview will focus
on gaining information about the youth respondent'slife that may be associatedwith tobacco use,
and includes questionson parental supervision,parental risk perceptionsoftobacco use, school
performance,and tobaccouse by youth. The adult and youth extendedinterview will collect
information related to attitudesand beliefs regarding harmful constituents,risk perceptions,
demographics(e.g., date of birth, gender,race, ethnicity, sexual identity, orientation, and
attraction, householdincome, pregnancystatus),environmentalfactors, family and peer
influences,generalhealth, and health effects.
Data will be identified by unique numbersassignedto eachrespondentand will be maintained in
separate,encryptedtables,with passwordprotection and accesslimited to authorizedpersonnel.
The ID numberswill link the respondent'sextendedinterview responseswith his or her own
biospecimens. Crosswalksthat match thesenumbersto personally identifiable information (PII)
will be stored in secure,encryptedfiles accessibleonly to authorizedstaff whose roles on the
study necessitateaccess. Authorized userswill have accessto researchdata free of PII only
behind a securedata firewall that will not permit downloading or printing of data.

Page2 -NIDA PATH Study- SecondWave of Data Collection
NIDA will not have accessto identi$ing information, and personalidentifiers will not be
included in the data receivedbyNIDA. Westat will transfer all data for the PATH study and
associatedproducts and documentsto NIDA at the time final data files are compiled, and will not
retain any records of the data.
I have determinedthat the Privacy Act will apply to this data collection. It will involve the
collection of personalinformation such as name,phone number, date of birth, address,phone
number, blood and urine sample,and information related to tobacco initiation, cessationand
relapsebehaviors,all of which will be retrieved by a unique identifier.
The data collection is coveredby NIH Privacy Act Systemsof Record 09-25-0200,ooClinical,
Basic and Population-basedResearchStudiesof the National Institutes of Health (NIH),
HHSAIIH/OD."
lf you have questions,pleaseme at (301) 402-620L.

p/;
fi*ar\l

Karen M. Pl6
Attachment
NIDA PRA Liaison
cc: GenevievedeAlmedia-Morris,

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

09-25-0200 SYSTEMS LISTING
SYSTEM NAME:
Clinical, Basic and Population-based Research Studies of the National Institutes of Health (NIH),
HHS/NIH/OD.
SECURITY CLASSIFICATION:
None.
SYSTEM LOCATION:
Records are located at NIH and Contractor research facilities which collect or provide research
data for this system. Contractors may include, but are not limited to: Research centers, clinics,
hospitals, universities, medical schools, research institutions/foundations, national associations,
commercial organizations, collaborating State and Federal Government agencies, and
coordinating centers. A current list of sites, including the address of any Federal Records Center
where records from this system may be stored, is available by writing to the appropriate
Coordinator listed under Notification Procedure.
CATEGORIES OF INDIVIDUALS COVERED BY THE SYSTEM:
Adults and/or children who are the subjects of clinical, basic, or population-based research
studies of the NIH. Individuals with disease. Individuals who are representative of the general
population or of special groups including, but not limited to: normal controls, normal volunteers,
family members and relatives; providers of services (e.g., health care and social work); health
care professionals and educators, and demographic sub-groups as applicable, such as age, sex,
ethnicity, race, occupation, geographic location; and groups exposed to real and/or hypothesized
risks (e.g., exposure to biohazardous microbial agents).
CATEGORIES OF RECORDS IN THE SYSTEM:
The system contains data about individuals as relevant to a particular research study. Examples
include, but are not limited to: name, study identification number, address, relevant telephone
numbers, social security number (voluntary), driver's license number, date of birth, weight,
height, sex, race; medical, psychological and dental information, laboratory and diagnostic
testing results; registries; social, economic and demographic data; health services utilization;
insurance and hospital cost data, employers, conditions of the work environment, exposure to
hazardous substances/compounds; information pertaining to stored biologic specimens
(including blood, urine, tissue and genetic materials), characteristics and activities of health care
providers and educators and trainers (including curricula vitae); and associated correspondence.

1

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

AUTHORITY FOR MAINTENANCE OF THE SYSTEM:
"Research and Investigation," "Appointment and Authority of the Directors of the National
Research Institutes," "National Cancer Institute," "National Eye Institute," "National Heart, Lung
and Blood Institute," "National Institute on Aging," "National Institute on Alcohol Abuse and
Alcoholism," "National Institute on Allergy and Infectious Diseases," "National Institute of
Arthritis and Musculoskeletal and Skin Diseases," "National Institute of Child Health and
Human Development," "National Institute on Deafness and Other Communication Disorders,"
"National Institute of Dental and Craniofacial Research," "National Institute of Diabetes, and
Digestive and Kidney Diseases," "National Institute of Drug Abuse," "National Institute of
Environmental Health Sciences," "National Institute of Mental Health," "National Institute of
Neurological Disorders and Stroke," and the "National Human Genome Research Institute" of
the Public Health Service Act. (42 U.S.C. 241, 242, 248, 281, 282, 284, 285a, 285b, 285c, 285d,
285e, 285f, 285g, 285h, 285i, 285j, 285l, 285m, 285n, 285o, 285p, 285q, 287, 287b, 287c, 289a,
289c, and 44 U.S.C. 3101.)
PURPOSE(S):
To document, track, monitor and evaluate NIH clinical, basic, and population-based research
activities.
ROUTINE USES OF RECORDS MAINTAINED IN THE SYSTEM, INCLUDING
CATEGORIES OF USERS AND THE PURPOSES OF SUCH USES:
1. A record may be disclosed for a research purpose, when the Department: (A) has determined that
the use or disclosure does not violate legal or policy limitations under which the record was
provided, collected, or obtained; e.g., disclosure of alcohol or drug abuse patient records will be
made only in accordance with the restrictions of confidentiality statutes and regulations 42 U.S.C.
241, 42 U.S.C. 290dd-2, 42 CFR Part 2, and where applicable, no disclosures will be made
inconsistent with an authorization of confidentiality under 42 U.S.C. 241 and 42 CFR Part 2a; (B)
has determined that the research purpose (1) cannot be reasonably accomplished unless the record
is provided in individually identifiable form, and (2) warrants the risk to the privacy of the
individual that additional exposure of the record might bring; (C) has required the recipient to (1)
establish reasonable administrative, technical, and physical safeguards to prevent unauthorized
use or disclosure of the record, (2) remove or destroy the information that identifies the individual
at the earliest time at which removal or destruction can be accomplished consistent with the
purpose of the research project, unless the recipient has presented adequate justification of a
research or health nature for retaining such information, and (3) make no further use or disclosure
of the record except (a) in emergency circumstances affecting the health or safety of any
individual, (b) for use in another research project, under these same conditions, and with written
authorization of the Department, (c) for disclosure to a properly identified person for the purpose
of an audit related to the research project, if information that would enable research subjects to be
identified is removed or destroyed at the earliest opportunity consistent with the purpose of the
audit, or (d) when required by law; and (D) has secured a written statement attesting to the
recipient's understanding of, and willingness to abide by, these provisions.
2. Disclosure may be made to a Member of Congress or to a Congressional staff member in
response to an inquiry of the Congressional office made at the written request of the constituent
about whom the record is maintained.

2

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

3. The Department of Health and Human Services (HHS) may disclose information from this
system of records to the Department of Justice when: (a) The agency or any component thereof;
or (b) any employee of the agency in his or her official capacity where the Department of Justice
has agreed to represent the employee; or (c) the United States Government, is a party to litigation
or has an interest in such litigation, and by careful review, the agency determines that the records
are both relevant and necessary to the litigation and the use of such records by the Department of
Justice is, therefore, deemed by the agency to be for a purpose that is compatible with the purpose
for which the agency collected the records.
4. Disclosure may be made to agency contractors, grantees, experts, consultants, collaborating
researchers, or volunteers who have been engaged by the agency to assist in the performance of a
service related to this system of records and who need to have access to the records in order to
perform the activity. Recipients shall be required to comply with the requirements of the Privacy
Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
5. Information from this system may be disclosed to Federal agencies, State agencies (including the
Motor Vehicle Administration and State vital statistics offices, private agencies, and other third
parties (such as current or prior employers, acquaintances, relatives), when necessary to obtain
information on morbidity and mortality experiences and to locate individuals for follow-up
studies. Social security numbers, date of birth and other identifiers may be disclosed: (1) to the
National Center for Health Statistics to ascertain vital status through the National Death Index;
(2) to the Health Care Financing Agency to ascertain morbidities; and (3) to the Social Security
Administration to ascertain disabilities and/or location of participants. Social security numbers
may also be given to other Federal agencies, and State and local agencies when necessary to
locating individuals for participation in follow-up studies.
6. Medical information may be disclosed in identifiable form to tumor registries for maintenance of
health statistics, e.g., for use in research studies.
7. PHS may inform the sexual and/or needle-sharing partner(s) of a subject individual who is
infected with the human immunodeficiency virus (HIV) of their exposure to HIV, under the
following circumstances: (1) The information has been obtained in the course of clinical activities
at PHS facilities carried out by PHS personnel or contractors; (2) The PHS employee or
contractor has made reasonable efforts to counsel and encourage the subject individual to provide
the information to the individual's sexual or needle-sharing partner(s); (3) The PHS employee or
contractor determines that the subject individual is unlikely to provide the information to the
sexual or needle-sharing partner(s) or that the provision of such information cannot reasonably be
verified; and (4) The notification of the partner(s) is made, whenever possible, by the subject
individual's physician or by a professional counselor and shall follow standard counseling
practices.

PHS may disclose information to State or local public health departments, to assist in the
notification of the subject individual's sexual and/or needle-sharing partner(s), or in the
verification that the subject individual has notified such sexual or needle-sharing
partner(s).
8. Certain diseases and conditions, including infectious diseases, may be reported to appropriate
representatives of State or Federal Government as required by State or Federal law.
9. Disclosure may be made to authorized organizations which provide health services to subject
individuals or provide third-party reimbursement or fiscal intermediary functions, for the purpose
of planning for or providing such services, billing or collecting third-party reimbursements.
10. The Secretary may disclose information to organizations deemed qualified to carry out quality
assessment, medical audits or utilization reviews.

3

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

11. Disclosure may be made for the purpose of reporting child, elder or spousal abuse or neglect or
any other type of abuse or neglect as required by State or Federal law.

POLICIES AND PRACTICES FOR STORING, RETRIEVING, ACCESSING,
RETAINING, AND DISPOSING OF RECORDS IN THE SYSTEM:
STORAGE:
Records may be stored on index cards, file folders, computer tapes and disks (including optical
disks), photography media, microfiche, microfilm, and audio and video tapes. For certain studies,
factual data with study code numbers are stored on computer tape or disk, while the key to
personal identifiers is stored separately, without factual data, in paper/computer files.
RETRIEVABILITY:
During data collection stages and follow-up, retrieval is by personal identifier (e.g., name, social
security number, medical record or study identification number, etc.). During the data analysis
stage, data are normally retrieved by the variables of interest (e.g., diagnosis, age, occupation).
SAFEGUARDS:
1. Authorized Users: Access to identifiers and to link files is strictly limited to the authorized
personnel whose duties require such access. Procedures for determining authorized access to
identified data are established as appropriate for each location. Personnel, including contractor
personnel, who may be so authorized include those directly involved in data collection and in the
design of research studies, e.g., interviewers and interviewer supervisors; project managers; and
statisticians involved in designing sampling plans. Other one-time and special access by other
employees is granted on a need-to-know basis as specifically authorized by the system manager.
Researchers authorized to conduct research on biologic specimens will typically access the
system through the use of encrypted identifiers sufficient to link individuals with records in such
a manner that does not compromise confidentiality of the individual.
2. Physical Safeguards: Records are either stored in locked rooms during off-duty hours, locked file
cabinets, and/or secured computer facilities. For certain studies, personal identifiers and link files
are separated and stored in locked files. Computer data access is limited through the use of key
words known only to authorized personnel.
3. Procedural Safeguards: Collection and maintenance of data is consistent with legislation and
regulations in the protection of human subjects, informed consent, confidentiality, and
confidentiality specific to drug and alcohol abuse patients where these apply. When anonymous
data is provided to research scientists for analysis, study numbers which can be matched to
personal identifiers will be eliminated, scrambled, or replaced by the agency or contractor with
random numbers which cannot be matched. Contractors who maintain records in this system are
instructed to make no further disclosure of the records. Privacy Act requirements are specifically
included in contracts for survey and research activities related to this system. The OHS project
directors, contract officers, and project officers oversee compliance with these requirements.
Personnel having access are trained in Privacy Act requirements. Depending upon the sensitivity
of the information in the record, additional safeguard measures may be employed.
4. Implementation Guidelines: These practices are in compliance with the standards of Chapter 4513 of the HHS General Administration Manual, "Safeguarding Records Contained in Systems of

4

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

Records," supplementary Chapter PHS hf: 45-13, and the HHS Automated Information Systems
Security Program Handbook.

RETENTION AND DISPOSAL:
Records are retained and disposed of under the authority of the NIH Records Control Schedule
contained in NIH Manual Chapter 1743, Appendix 1B "Keeping and Destroying Records" (HHS
Records Management Manual, Appendix B-361), item 3000-G-3, which allows records to be
kept as long as they are useful in scientific research. Collaborative Perinatal Project records are
retained in accordance with item 3000-G-4, which does not allow records to be destroyed. Refer
to the NIH Manual Chapter for specific conditions on disposal or retention instructions.
SYSTEM MANAGER(S) AND ADDRESS(ES):
See Appendix I for a listing of current System Managers. This system is for use by all NIH
Institutes and Centers.
NOTIFICATION PROCEDURE:
To determine if a record exists, write to the appropriate IC Privacy Act Coordinator listed below.
In cases where the requester knows specifically which System Manager to contact, he or she may
contact the System Manager directly (See Appendix I). Notification requests should include:
individual's name; current address; date of birth; date, place and nature of participation in
specific research study; name of individual or organization administering the research study (if
known); name or description of the research study (if known); address at the time of
participation; and in specific cases, a notarized statement (some highly sensitive systems require
two witnesses attesting to the individual's identity). A requester must verify his or her identity by
providing either a notarization of the request or by submitting a written certification that the is
who he or she claims to be and understands that the knowing and willful request for acquisition
of a record pertaining to an individual under false pretenses is a criminal offense under the Act,
subject to a five thousand dollar fine.
Individuals will be granted direct access to their medical records unless the System Manager
determines that such access is likely to have an adverse effect (i.e., could cause harm) on the
individual. In such cases when the System Manager has determined that the nature of the record
information requires medical interpretation, the subject of the record shall be requested to
designate, in writing, a responsible representative who will be willing to review the record and
inform the subject individual of its contents at the representative's discretion. The representative
may be a physician, other health professional, or other responsible individual. In this case, the
medical/dental record will be sent to the designated representative. Individuals will be informed
in writing if the record is sent to the representative. This same procedure will apply in cases
where a parent or guardian requests notification of, or access to, a child's or incompetent person's
medical record. The parent or guardian must also verify (provide adequate documentation) their
relationship to the child or incompetent person as well as his or her own identity to prove their
relationship.

5

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

If the requester does not know which Institute or Center Privacy Act Coordinator to contact for
notification purposes, he or she may contact directly the NIH Privacy Act Officer at the
following address: NIH Privacy Act Officer, Office of Management Assessment, 6011 Executive
Blvd., Room 601L, Rockville, MD 20852.
NIH Privacy Act Coordinators
Associate Director for Disease Prevention, Office of the Director (OD), Building 1, Room 260, 1
Center Drive, Bethesda, MD 20892.
Privacy Act Coordinator, Clinical Center (CC), Building 10, Room 1N208, 10 Center Drive,
Bethesda, MD 20892.
Privacy Act Coordinator, National Center for Complementary and Alternative Medicine
(NCCAM), Building 31, Room 2B11, 31 Center Drive, Bethesda, MD 20892-2182.
Privacy Act Coordinator, National Cancer Institute (NCI), Building 31, Room 10A34, 31 Center
Drive, Bethesda, MD 20892.
Privacy Act Coordinator, National Center on Minority Health and Health Disparities (NCMHD),
Democracy Plaza II, Room 800, 6707 Democracy Boulevard, Bethesda, MD 20892-5465.
Privacy Act Coordinator, National Center for Research Resources (NCRR), Rockledge I, Room
5140, 6705 Rockledge Drive, Bethesda, MD 20892.
Privacy Act Coordinator, National Eye Institute (NEI), Building 31, Room 6A32, 31 Center
Drive, Bethesda, MD 20892-2510.
Privacy Act Coordinator, National Human Genome Research Institute (NHGRI), Building 10,
3C710, 10 Center Drive, Bethesda, MD 20892.
Privacy Act Coordinator, National Heart, Lung, and Blood Institute (NHLBI), Building 31,
Room 5A33, 31 Center Drive, Bethesda, MD 20892.
Privacy Act Coordinator, National Institute on Aging (NIA), Gateway Building 31, Room
2C234, 7201 Wisconsin Avenue, Bethesda, MD 20892.
Privacy Act Coordinator, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Willco
Building, Room 400, 6000 Executive Boulevard, Bethesda, MD 20892-7003.
Privacy Act Coordinator, National Institute of Allergy and Infectious Diseases (NIAID), 6700-B
Rockledge Drive, Room 2143, Bethesda, MD 20892.
Privacy Act Coordinator, National Institute of Arthritis and Musculoskeletal and Skin Diseases
(NIAMS), Natcher Building, Room 5AS49, 45 Center Drive, Bethesda, MD 20892.

6

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

Privacy Act Coordinator, National Institute of Biomedical Imaging and Bioengineering (NIBIB),
Building 31, Room 1B37, 31 Center Drive, Bethesda, MD 20892-2077.
Privacy Act Coordinator, National Institute of Child Health and Human Development (NICHD),
Building 31, Room 2A11, 31 Center Drive, Bethesda, MD 20892.
Privacy Act Coordinator, Office of Extramural Affairs, National Institute on Drug Abuse
(NIDA), Neuroscience Center, 6001 Executive Boulevard, Room 3158, Bethesda, MD 208929547.
Privacy Act Coordinator, National Institute on Deafness and Other Communication Disorders
(NIDCD), Building 31, Room 3C02, 31 Center Drive, Bethesda, MD 20892.
Privacy Act Coordinator, National Institute of Dental and Craniofacial Research (NIDCR),
Natcher Building, Room 4AS25, 45 Center Drive, Bethesda, MD 20892-6401.
Privacy Act Coordinator, National Institute of Diabetes and Digestive and Kidney Disease
(NIDDK), Building 31, Room 9A47, 31 Center Drive, Bethesda, MD 20892.
Privacy Act Coordinator, National Institute of Environmental Health Sciences (NIEHS), P.O.
Box 12233, Research Triangle Park, NC 27709.
Privacy Act Coordinator, National Institute of General Medical Sciences (NIGMS), Natcher
Building, Room 2AN32, 45 Center Drive, Bethesda, MD 20892.
Privacy Act Coordinator, National Institute of Mental Health (NIMH), Neuroscience Center,
6001 Executive Boulevard, Room 8102, Bethesda, MD 20892.
Privacy Act Coordinator, National Institute of Neurological Disorders and Stroke (NINDS),
Building 31, Room 8A33, 31 Center Drive, Bethesda, MD 20892.
Privacy Act Coordinator, National Institute of Nursing Research (NINR), Rockledge II, Room
710, 6701 Rockledge Drive, Bethesda, MD 20892.
RECORD ACCESS PROCEDURE:
Same as Notification Procedures. Requesters should reasonably specify the record contents being
sought. An individual may also request an accounting of disclosures of his/her record, if any.

7

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

CONTESTING RECORD PROCEDURE:
Contact the appropriate official at the address specified under Notification Procedure, and
reasonably identify the record, specify the information being contested, and state corrective
action sought, with supporting information to show how the record is inaccurate, incomplete,
untimely, or irrelevant.
RECORD SOURCE CATEGORIES:
The system contains information obtained directly from the subject individual by interview
(face-to-face or telephone), written questionnaire, or by other tests, recording devices or
observations, consistent with legislation and regulation regarding informed consent and
protection of human subjects. Information is also obtained from other sources, including but not
limited to: referring medical physicians, mental health/alcohol/drug abuse or other health care
providers; hospitals; organizations providing biological specimens; relatives; guardians; schools;
and clinical medical research records.
SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS OF THE ACT:
None.
Appendix I: System Manager(s) and Address(es)
Associate Director for Disease Prevention, Office of the Director (OD), Building 1, Room 260, 1
Center Drive, Bethesda, MD 20892.
Computer Systems Analyst, Division of Cancer Treatment and Diagnosis, National Cancer
Institute (NCI), Executive Plaza North, Room 344, 6130 Executive Boulevard, Bethesda, MD
20892.
American Burkitt's Lymphoma Registry, Division of Cancer Etiology, National Cancer Institute
(NCI), Executive Plaza North, Suite 434, 6130 Executive Boulevard, Bethesda, MD 20892.
Chief, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National
Cancer Institute (NCI), Executive Plaza South, Room 7122, 6120 Executive Boulevard,
Bethesda, MD 20892-7236.
Program Director, Research Resources, Biological Carcinogenesis Branch, Division of Cancer
Etiology, National Cancer Institute (NCI), Executive Plaza North, Room 540, 6130 Executive
Boulevard, Bethesda, MD 20892.
Chief, Environmental Epidemiology Branch, Division of Cancer Etiology, National Cancer
Institute (NCI), Executive Plaza North, Room 443, 6130 Executive Boulevard, Bethesda, MD
20892.

8

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

Associate Director, Surveillance Program, Division of Cancer Prevention, National Cancer
Institute (NCI), Executive Plaza North, Room 343K, 6130 Executive Boulevard, Bethesda, MD
20892.
Head, Biostatistics and Data Management Section, Center for Cancer Research, National Cancer
Institute (NCI), Building 6116, Room 702, 6116 Executive Boulevard, Bethesda, MD 20892.
Chief, Clinical Research Branch, Center for Cancer Research, Frederick Cancer Research and
Development Center, National Cancer Institute (NCI), 501 W. 7th Street, Room 3, Frederick,
MD 21702.
Deputy Branch Chief, Navy Hospital, NCI-Naval Medical Oncology Branch, Center for Cancer
Research, National Cancer Institute (NCI), Building 8, Room 5101, Bethesda, MD 20814.
Chief, Pharmaceutical Management Branch, Cancer Therapy Evaluation Program, Division of
Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Executive Plaza North, Room
804, 6130 Executive Boulevard, Bethesda, MD 20892.
Director, Extramural Clinical Studies, Frederick Cancer Research and Development Center,
National Cancer Institute (NCI), Fort Detrick, Frederick, MD 21702.
Clinical Operations Manager, National Eye Institute (NEI), Building 10, Room 10S224, 10
Center Drive, Bethesda, MD 20892.
Director, Division of Biometry and Epidemiology, National Eye Institute (NEI), Building 31,
Room 6A52, 31 Center Drive, Bethesda, MD 20892.
Associate Director, Office of Clinical Affairs, National Heart, Lung, and Blood Institute
(NHLBI), Building 10, Room 8C104,10 Center Drive, Bethesda, MD 20892-1754.
Senior Scientific Advisor, Office of the Director, Division of Epidemiology and Clinical
Applications, National Heart, Lung, and Blood Institute (NHLBI), Federal Building, Room 220,
7550 Wisconsin Avenue, Bethesda, MD 20892.
Chief Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging
(NIA), Gateway Building, Room 3C309, 7201 Wisconsin Avenue, Bethesda, MD 20892.
Chief, Research Resources Branch, Intramural Research Program, National Institute on Aging
(NIA), 5600 Nathan Shock Drive, Baltimore, MD 21224.
Clinical Director, National Institute on Aging (NIA), 5600 Nathan Shock Drive, Baltimore, MD
21224.
Deputy Director, Division of Biometry and Epidemiology, National Institute on Alcohol Abuse
and Alcoholism (NIAAA), Willco Building, Room 514, 6000 Executive Boulevard, Bethesda,
MD 20892-7003.

9

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

Deputy Director, Division of Clinical and Prevention Research, National Institute on Alcohol
Abuse and Alcoholism (NIAAA), Willco Building, Room 505, 6000 Executive Boulevard,
Bethesda, MD 20892-7003.
Chief, Respiratory Viruses Section, Laboratory of Infectious Diseases, National Institute of
Allergy and Infectious Diseases (NIAID), Building 7, Room 106, 7 Memorial Drive, Bethesda,
MD 20892.
Chief, Hepatitis Virus Section, Laboratory of Infectious Diseases, National Institute of Allergy
and Infectious Diseases (NIAID), Building 7, Room 202, 7 Memorial Drive, Bethesda, MD
20892.
Chief, Biometry Branch, Division of Microbiology and Infectious Diseases, National Institute of
Allergy and Infectious Diseases (NIAID), 6700-B Rockledge Drive, Room 3120, Bethesda, MD
20892.
Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases
(NIAMS), Building 10, Room 9S205, 10 Center Drive, Bethesda, MD 20892.
Chief, Contracts Management Branch, National Institute of Child Health and Human
Development (NICHD), Executive Plaza North, Room 7A07, 6130 Executive Boulevard,
Bethesda, MD 20892.
Director of Intramural Research, National Institute on Deafness and Other Communication
Disorders (NIDCD), Building 31, Room 3C02, 31 Center Drive, Bethesda, MD 20892.
Chief, Scientific Programs Branch, National Institute on Deafness and Other Communication
Disorders (NIDCD), Executive Plaza South, Room 400C, 6120 Executive Boulevard, Bethesda,
MD 20892-7180.
Clinical Director, National Institute of Dental and Craniofacial Research (NIDCR), Building 10,
Room 1N117, 10 Center Drive, Bethesda, MD 20892-1191.
Chief, Scientific Review Branch, National Institute of Dental and Craniofacial Research
(NIDCR), Building 10, Room 1N117, 10 Center Drive, Bethesda, MD 20892-1191.
Research Psychologist, Gene Therapy and Therapeutics Branch, National Institute of Dental and
Craniofacial Research (NIDCR), Building 10, Room 1N105, 10 Center Drive, Bethesda, MD
20892-1190.
Chief, Clinical Investigations, National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK), Building 10, Room 9N222, 10 Center Drive, Bethesda, MD 20892.
Chief, Phoenix Clinical Research Section, National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK), Phoenix Area Indian Hospital, Room 541, 4212 North 16th Street,
Phoenix, AZ 85016.

10

Population Assessment of Tobacco and Health (PATH) Study (NIDA)

Chief, Diabetes Research Section, Division of Diabetes, Endocrinology, and Metabolic Diseases,
National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), Natcher Building,
Room 5AN18G, 45 Center Drive, Bethesda, MD 20892-6600.
Privacy Act Coordinator, Office of Extramural Affairs, National Institute on Drug Abuse
(NIDA), 6001 Executive Boulevard, Room 3158, Bethesda, MD 20892-9547.
Chief, Epidemiology Branch, National Institute of Environmental Health Sciences (NIEHS),
P.O. Box 12233, Research Triangle Park, NC 27709.
Director, Intramural Research Program, National Institute of Mental Health (NIMH), Building
10, Room 4N224, 10 Center Drive, Bethesda, MD 20892.
Privacy Act Coordinator, National Institute of Mental Health (NIMH), Neuroscience Center,
Room 8102, 6001 Executive Boulevard, Bethesda, MD 20982.
Privacy Act Coordinator, National Institute of Neurological Disorders and Stroke (NINDS),
Building 31, Room 8A33, 31 Center Drive, Bethesda, MD 20892.
Chief, Epilepsy Branch, National Institute of Neurological Disorders and Stroke (NINDS),
Neuroscience Center, 6001 Executive Boulevard, Suite 2110, Bethesda, MD 20892-9523.
Assistant Director, Clinical Neurosciences Program, Division of Intramural Research, National
Institute of Neurological Disorders and Stroke (NINDS), Building 10, Room 5N234, 10 Center
Drive, Bethesda, MD 20892.
Acting Chief, Laboratory of Central Nervous Systems Studies, Intramural Research Program,
National Institute of Neurological Disorders and Stroke (NINDS), Building 36, Room 4A21, 36
Convent Drive, Bethesda, MD 20892-4123.
Clinical Director, National Human Genome Research Institute (NHGRI), Building 10, Room
10C101D, 10 Center Drive, Bethesda, MD 20892.
Deputy Director, Division of Extramural Research, National Institute of Neurological Disorders
and Stroke (NINDS), Neuroscience Center, Room 3307, 6001 Executive Boulevard, Bethesda,
MD 20892.
Director, Office of Clinical and Regulatory Affairs, Division of Extramural Research and
Training, Democracy Plaza II, Room 401, 6707 Democracy Boulevard, Bethesda, MD 208925475.
Privacy Act Coordinator, National Institute of Biomedical Imaging and Bioengineering (NIBIB),
Building 31, Room 1B37, 31 Center Drive, Bethesda, MD 20892-2077.
Privacy Act Coordinator, National Center on Minority Health and Health Disparities (NCMHD),
Democracy Plaza II, Room 800, 6707 Democracy Boulevard, Bethesda, MD 20892-5465.

11